Zim Laboratories Announces Q4 & FY26 Earnings Conference Call on 20 May 2026
Zim Laboratories will hold a Q4 & FY26 earnings conference call on May 20, 2026, at 12:00 p.m. IST. Key participants include Dr. Anwar Siraj Daud, Mr. Zulfiquar Kamal, Mr. Shyam Mohan Patro, and Mr. Zain Daud. The call is hosted by Go India Advisors. Participants can pre-register or dial in using the provided numbers.
The announcement is about scheduling a conference call, which has a low impact on the company's operations.
The announcement is a routine update regarding the schedule of an earnings conference call.
Zim Laboratories Limited has announced that its Q4 & FY26 Earnings Conference Call will be held on Wednesday, 20th May 2026, at 12:00 p.m. IST. This event is pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The conference call will be hosted by Go India Advisors. The key participants from the company will include Dr. Anwar Siraj Daud (Chairman and Managing Director), Mr. Zulfiquar Kamal (Director - Finance), Mr. Shyam Mohan Patro (Chief Financial Officer), and Mr. Zain Daud (Investor Relations).
To join the call, participants can pre-register to avoid wait times using the provided registration link. Alternatively, participants can dial in 5-10 minutes prior to the scheduled time using the universal dial-in numbers 086 3416 8787 & 086 4536 6906. For further information, individuals may contact Sheetal Khanduja at sheetal@goindiaadvisors.com or Deepika Sharma at deepika@goindiaadvisors.com.
What to do with a filing like this
Zim Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zim Laboratories Limited. Read the original for the full detail.